Tyra Biosciences COO receives RSU and option grants
Tyra Biosciences Chief Operating Officer Ashar Bhavesh received new equity awards in the form of restricted stock units and stock options.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Tyra Biosciences Chief Operating Officer Ashar Bhavesh received new equity awards in the form of restricted stock units and stock options. On May 5, 2026, Bhavesh was granted 15,013 RSUs, each representing a right to receive one share of common stock, and 50,295 stock options with an exercise price of $33.93 per share.
According to the vesting terms, one quarter of the RSUs vests on each of the first four anniversaries of May 5, 2026, subject to continued service. For the options, 25% of the shares vest on May 5, 2027 and the remainder vests in equal monthly installments over the following three years, with the options expiring on May 4, 2036.
Insider Trade Summary
Grant/Award: 65,308 shares
Grant/Award
2 txns
Insider
Ashar Bhavesh
Role
Chief Operating Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 50,295 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 15,013 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 50,295 contracts (Direct);
Common Stock — 15,013 shares (Direct)
Footnotes (3)
- F1. Represents restricted stock units ("RSUs") granted on May 5, 2026. 1/4 of the total number of RSUs granted vest on each of the first four anniversaries of May 5, 2026, the vesting commencement date, subject to the Reporting Person's continuous service through each vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
- F2. Includes RSUs.
- F3. 25% of the shares subject to the option shall vest on May 5, 2027, and 1/48th of the total number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
Key Figures
RSUs granted: 15,013 shares
Options granted: 50,295 options
Option exercise price: $33.93 per share
+3 more
6 metrics
RSUs granted
15,013 shares
Restricted stock units granted to COO on May 5, 2026
Options granted
50,295 options
Stock options granted to COO on May 5, 2026
Option exercise price
$33.93 per share
Exercise price for 50,295 stock options
Option expiration
May 4, 2036
Expiration date of COO stock options
RSU vesting schedule
25% annually over 4 years
Annual vesting from May 5, 2026 anniversaries
Option vesting start
25% on May 5, 2027
Initial cliff vesting for options
Key Terms
restricted stock units ("RSUs"), Stock Option (Right to Buy), exercise price, vesting
4 terms
restricted stock units ("RSUs") financial
"Represents restricted stock units ("RSUs") granted on May 5, 2026."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with an exercise price of 33.9300."
exercise price financial
"conversion_or_exercise_price: "33.9300" for the stock option grant."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"1/4 of the total number of RSUs granted vest on each of the first four anniversaries."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Tyra Biosciences (TYRA) report for Ashar Bhavesh?
Tyra Biosciences reported that Chief Operating Officer Ashar Bhavesh received equity awards, including restricted stock units and stock options. These awards are compensation-related grants, not open-market purchases or sales, and vest over several years subject to his continued service with the company.
How many RSUs did Tyra Biosciences grant to COO Ashar Bhavesh?
Ashar Bhavesh received 15,013 restricted stock units (RSUs) on May 5, 2026. Each RSU represents a contingent right to receive one share of Tyra Biosciences common stock, with vesting spread over four years, conditioned on his continued service with the company through each vesting date.
What are the terms of Ashar Bhavesh’s new stock options at Tyra Biosciences (TYRA)?
Bhavesh was granted 50,295 stock options with an exercise price of $33.93 per share. Twenty-five percent vests on May 5, 2027, and the remaining options vest in equal monthly installments over the next three years, expiring on May 4, 2036, subject to continued service.
Are Ashar Bhavesh’s recent Tyra Biosciences equity grants open-market purchases?
No. The Form 4 shows compensation-related grants, not market trades. Both the 15,013 RSUs and 50,295 stock options were awarded at no purchase price, reflecting equity-based compensation that vests over time if Bhavesh remains in continuous service with Tyra Biosciences.
How do the RSUs granted to Tyra Biosciences’ COO vest over time?
The 15,013 RSUs granted to Ashar Bhavesh vest in four equal annual installments. One quarter of the total RSUs vests on each of the first four anniversaries of May 5, 2026, provided he continues to serve Tyra Biosciences through each applicable vesting date.
When do Ashar Bhavesh’s Tyra Biosciences stock options expire?
The stock options granted to Ashar Bhavesh on May 5, 2026 expire on May 4, 2036. This provides a ten-year term during which, once vested, he may choose to exercise the options at the stated $33.93 per-share exercise price, subject to applicable plan rules.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates